Stefano Del Prato

Sep 16, 2024 | dom-pubs.onlinelibrary.wiley.com | Hertzel C. Gerstein |Stefano Del Prato |Renato D. Lopes |Richard E. Pratley

1 BACKGROUND/CONTEXT Glucagon-like-peptide-1 receptor agonists (GLP-1 RA) lower HbA1c by promoting insulin secretion in response to elevated glucose (the incretin effect).1, 2 They also slow gastric emptying; reduce appetite, weight, blood pressure, low-density lipoprotein (LDL) cholesterol and serious health outcomes3; and increase heart rate and pancreatic enzymes. The degree to which these nonglycaemic effects mediate their glycaemic effects remains unclear.

Apr 8, 2024 | jacc.org | James L. Januzzi |Javed Butler |Stefano Del Prato |Justin A. Ezekowitz

References1. "Heart failure: an underappreciated complication of diabetes. A consensus report of the American Diabetes Association". Diabetes Care . 2022;45:7: 1670-1690. 2. "High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes". Diabetologia . 2012;55:8: 2154-2162. 3.

Mar 3, 2023 | thelancet.com | Stefano Del Prato

Cookie Preference CenterWe use cookies which are necessary to make our site work. We may also use additional cookies to analyse, improve and personalise our content and your digital experience. For more information, see our Cookie Policy and the list of Google Ad-Tech Vendors. You may choose not to allow some types of cookies. However, blocking some types may impact your experience of our site and the services we are able to offer.